Lepu Medical to transfer 54.2384% stake in Shanghai Minwei Biotech to Xintai Medical for 1.088 billion yuan

CLS··CN·Read original
2▲0 ▼0Impact / 5
Summary · why it matters

Lepu Medical announced that it will transfer its 54.2384% stake in Shanghai Minwei Biotech to its controlling subsidiary Xintai Medical for 1.088 billion yuan. This transaction is an internal equity transfer within the company and does not involve any change in the scope of consolidated financial statements.

Impact on assets 1

Others▲ · 1 stocks

Off-coverage companies 1

上海民为生物技术有限公司Private± Mixed
Capitalrelevance

Company is subject of stake transfer, but not publicly listed and impact not specified.

© 2026 MarketIVNews